You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Amgen to acquire gene firm for $415m

NEW YORK — In a bid to bolster its drug discovery efforts, the biotechnology giant Amgen said Monday that it would pay $415 million to acquire deCODE Genetics, a gene-hunting business known for its headline-grabbing discoveries linking genetic variations to disease.

The companies are hoping the deal will be symbiotic. deCODE will get a well-financed partner to further its research, while Amgen is hoping to capitalize on the cutting-edge findings.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week